immune-path

Immune-Path (Yidao Biotechnology (Suzhou) Co., Ltd. / 怡道生物) is a China-based vaccine biotechnology company founded in 2017 and headquartered in Suzhou. The company develops human vaccines across recombinant protein antigen, novel viral vector, and messenger RNA (mRNA) platforms, backed by its own vaccine adjuvant technology. Its clinical and preclinical pipeline includes a recombinant zoster (shingles) vaccine produced in CHO cells, a nine-valent recombinant HPV vaccine expressed in Pichia pastoris, a respiratory syncytial virus (RSV) vaccine, a therapeutic gastric cancer vaccine, and a COVID-19 vaccine. Immune-Path is a portfolio company of Qiming Venture Partners. It is a life-sciences drug developer with no public developer, API, or software surface; this profile is maintained as a company record in the API Evangelist network.

immune-path is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Vaccines, Immunology, and Pharmaceuticals.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyVaccinesImmunologyPharmaceuticalsLife SciencesDrug DevelopmentmRNAHealthcareChina

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/immune-path: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: immune-path
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/immune-path.png
name: immune-path
description: Immune-Path (Yidao Biotechnology (Suzhou) Co., Ltd. / 怡道生物) is a China-based vaccine biotechnology company founded
  in 2017 and headquartered in Suzhou. The company develops human vaccines across recombinant protein antigen, novel viral
  vector, and messenger RNA (mRNA) platforms, backed by its own vaccine adjuvant technology. Its clinical and preclinical
  pipeline includes a recombinant zoster (shingles) vaccine produced in CHO cells, a nine-valent recombinant HPV vaccine expressed
  in Pichia pastoris, a respiratory syncytial virus (RSV) vaccine, a therapeutic gastric cancer vaccine, and a COVID-19 vaccine.
  Immune-Path is a portfolio company of Qiming Venture Partners. It is a life-sciences drug developer with no public developer,
  API, or software surface; this profile is maintained as a company record in the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/immune-path/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
x-no-api-surface: true
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Vaccines
- Immunology
- Pharmaceuticals
- Life Sciences
- Drug Development
- mRNA
- Healthcare
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://immune-path.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence